MULTI-STATE MODELS ENHANCE INSIGHT IN OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML/MDS FOLLOWED BY DONOR LYMPHOCYTE INFUSIONS

被引：0
|
作者：
de Wreede, L. [1 ]
Eefting, M. [2 ]
Halkes, C. [2 ]
von dem Borne, P. [2 ]
Kersting, S. [2 ]
Marijt, E. [2 ]
Veelken, H. [2 ]
Putter, H. [1 ]
Schetelig, J. [3 ]
Falkenburg, J. [2 ]
机构：
[1] LUMC, Med Stat & Bioinformat, Leiden, Netherlands
[2] LUMC, Hematol, Leiden, Netherlands
[3] Univ Hosp Carl Gustav Carus, Dept Med 1, Dresden, Germany
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P399
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [1] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Giagounidis, A.
    Zohren, F.
    Bruns, I.
    Wolschke, C.
    Rieger, K.
    Fenk, R.
    Germing, U.
    Haas, R.
    Kroeger, N.
    Kobbe, G.
    LEUKEMIA, 2013, 27 (06) : 1229 - 1235
  • [2] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    T Schroeder
    A Czibere
    U Platzbecker
    G Bug
    L Uharek
    T Luft
    A Giagounidis
    F Zohren
    I Bruns
    C Wolschke
    K Rieger
    R Fenk
    U Germing
    R Haas
    N Kröger
    G Kobbe
    Leukemia, 2013, 27 : 1229 - 1235
  • [3] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation
    Czibere, A.
    Graef, T.
    Bruns, I.
    Zohren, F.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
  • [4] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation.
    Czibere, Akos
    Graef, Thorsten
    Lind, Jens
    Gattermann, Norbert
    Zohren, Fabian
    Fenk, Roland
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2006, 108 (11) : 428B - 428B
  • [5] Azacytidine And Donor Lymphocyte Infusions (DLI) as Salvage Treatment in Patients with AML And MDS Relapsed After Allogeneic Stem Cell Transplantation: A Retrospective Single Center Analysis
    Aydin, Semra
    Dellacasa, Chiara
    Iovino, Giorgia
    Manetta, Sara
    Rosso, Tiziana
    Ciccone, Giovannino
    GIaccone, Luisa
    Busca, Alessandro
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 185 - 185
  • [6] Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion
    Eefting, Matthias
    de Wreede, Liesbeth C.
    Halkes, Constantijn J. M.
    von dem Borne, Peter A.
    Kersting, Sabina
    Marijt, Erik W. A.
    Veelken, Hendrik
    Putter, Hein
    Schetelig, Johannes
    Falkenburg, J. H. Frederik
    HAEMATOLOGICA, 2016, 101 (04) : 506 - 514
  • [7] Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.
    Riera, L
    Koziner, B
    MEDICINA-BUENOS AIRES, 2000, 60 (02) : 259 - 269
  • [8] Donor lymphocyte infusions after allogeneic stem cell transplantation: single center clinical experience
    Kwon, Mi
    Serrano, David
    Gayoso, Jorge
    Anguita, Javier
    Buno, Ismael
    Luis Diez-Martin, Jose
    MEDICINA CLINICA, 2010, 135 (11): : 498 - 502
  • [9] Donor lymphocyte infusions in patients with leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Liu, YL
    Zhou, SY
    BLOOD, 2002, 100 (11) : 448B - 448B
  • [10] Efficacy of donor lymphocyte infusions in patients with lymphoid malignancies after allogeneic stem cell transplantation
    Slesarchuk, O. A.
    Semenova, E. V.
    Bondarenko, S. N.
    Babenko, E. V.
    Estrina, M. A.
    Mikhailova, N. B.
    Zubarovskaya, L.
    Afanasyev, B. V.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S257 - S257
12345